Frederic Kurt
Chief Financial and Corporate Officer ; Head of investor relations ; Head of instutional relations at Paris Saclay Cancer Cluster | Paris, Île-de-France, France
Frederic Kurt’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Frederic Kurt serves as Chief Financial and Corporate Officer at the Paris Saclay Cancer Cluster, where he concurrently directs investor relations and institutional partnership strategies. He is an alumnus of Université Paris Dauphine - PSL and brings prior executive finance experience holding Group CFO and VP Finance titles within the pharmaceutical sector. In his current capacity, he oversees financial governance and stakeholder engagement for a national non-profit foundation backed by major academic and industrial partners to accelerate cancer research and development.
BEST APPROACH TO REACH Frederic Kurt
Lean on the strong data availability for personal email to send a targeted outreach message that aligns your offering with the cluster’s Healthcare Innovation 2030 mandate before exploring other communication channels.
Chief Financial and Corporate Officer ; Head of investor relations ; Head of instutional relations at Paris Saclay Cancer Cluster in April 2022 - Present
Company Officer / Group CFO at Iconoclast Group in November 2019 - March 2022
CFO at Sony Pictures Entertainment in March 2007 - November 2019
Finance Controller at Sony Pictures Entertainment in November 2004 - March 2007
Head Of Financial Planning Analysis at Studiocanal in February 2002 - November 2004
Group Chief Accoutant Officer and SAP Project Manager at Studiocanal in October 2000 - January 2002
Head Of Royalties department at Studiocanal in May 1999 - September 2000
Senior Finance Auditor at KPMG France in September 1995 - May 1999
Business Analyst at Dalkia in September 1993 - March 1995
Université Paris Dauphine - PSL, Master in Finance, September 1988 to September 1993
The Paris Saclay Cancer Cluster (PSCC) is building a world-class biocluster to position France as the leading hub for cancer innovation. Selected by the French authorities as part of the Healthcare Innovation 2030 plan, the PSCC is a non-profit French Foundation for Scientific Cooperation (FCS) with a dual global ambition: ✅ Change the outcome of millions of patients fighting cancer worldwide ✅ Position France and Europe at the forefront of the 1st pharmaceutical industry A world-class ecosystem driving innovation Founded by Gustave Roussy, Sanofi, Inserm, Paris-Saclay University, and the Polytechnic Institute of Paris, the PSCC has rapidly expanded, welcoming key partners such as Unicancer, Institut Curie, AP-HP, and Medicen. With industry sponsors including Sanofi, Servier, GSK, IPSEN, and Merck, we act as a catalyst to transform breakthrough discoveries into industrial diagnostic and therapeutic solutions. To accelerate this transformation, the PSCC provides a thriving environment including: 🔹 A premier location at Campus Grand Parc, Europe's leading cancer innovation hub, offering office/lab spaces with optimal solutions and controlled investment 🔹 Project support, access to mentors, funding, and strategic networks 🔹 Real-world data, biological samples, advanced technological & clinical platforms 🔹 A dynamic network bringing together Researchers, clinicians, startups, biotechs, pharma leaders, CROs, investors, public authorities and patients Key Achievements & Impact 📌 150+ members within PSCC Connect 📌 50+ support companies (CROs, CDMOs, equipment providers, IP experts, etc.) 📌 Implementation at Campus Grand Parc 📌 5 academic platforms funded 📌 Major DATA initiative 📌 60 + projects supported to date, including: -> €118M raised by 13 startups -> 2 startups successfully acquired 🚀 Whether you're a startup, biotech, pharma company, CRO, or investor, join us and accelerate the next generation of cancer innovations!
Discover more about Paris Saclay Cancer ClusterSpécialiste santé au service de la coopération entre les acteurs #coconstruction #innovation
CInO - Directrice innovation et Conseil aux entreprises at Paris Saclay Cancer Cluster
(April 2022 – Present)
Senior Advisor at PSCC
Senior Advisor at Paris Saclay Cancer Cluster (PSCC)
(April 2024 – Present)
CEO of PSCC (Leading Biocluster of Innovation in Oncology in France)
Chief Executive Officer at Paris Saclay Cancer Cluster
(Apr 2022 – Present)
Entrepreneurship/student-professional events/Bio & Medtech 🧪🫀 Mines Paris-PSL/ Paris Saclay Cancer Cluster / VP of Bio’M - réseau Biotechno 🎓
Accompagnement des élèves dans les domaines scientifiques et le développement personnel
Objectif : démontrer que l élève peut y arriver
Director Innovation in Health/Biotech, Certified Board Member
- accompagnement d'un portefeuille de projets innovants en oncologie (thérapeutique, diagnostic et dispositif médical) (>30)
- revue de la stratégie de développement des projets
- aide à l'implantation sur le territoire
- identification et mise en relation avec les expert...
Accelerating New Therapies for Children with Cancer | Pediatric Oncology & Drug Discovery Expert | CSR Strategy & Global Partnerships | International Collaborations
Lead multistakeholder efforts to advance childhood cancer research and innovation.
Build bridges between academia, industry, startups, and patient groups to accelerate translational impact.
What is Frederic Kurt email address?
Email Frederic Kurt at [email protected] and [email protected]. This email is the most updated Frederic Kurt's email found in 2026.
How to contact Frederic Kurt?
To contact Frederic Kurt send an email to [email protected] or [email protected]. (updated on November 14, 2025)
What company does Frederic Kurt work for?
Frederic Kurt works for Paris Saclay Cancer Cluster.
What is Frederic Kurt's role at Paris Saclay Cancer Cluster?
Frederic Kurt is Chief Financial and Corporate Officer ; Head of investor relations ; Head of instutional relations
What industry does Frederic Kurt work in?
Frederic Kurt works in the Pharmaceuticals industry.
